True Leaf Pet, a wholly owned subsidiary of True Leaf International (CSE:MJ) has signed an agreement with Chuck Latham Associates that will see the firm represent the True Hemp product line to pet retailers like Petco, PetSmart, Pet Supplies Plus and Amazon.
As quoted in the press release:

CLA is known as ‘The Pet Channel Expert’ with four strategically located offices and over 800 company associates working across the United States. CLA is the leading firm in the pet specialty market that provides national coverage across all major sales channels, including independent pet stores, farm stores, national pet retailers, and internet retailers.
“This is a significant milestone for us,” said True Leaf CEO Darcy Bomford. “CLA is the gold-standard rep-firm in the pet industry and we’re happy to have their team represent our line across the U.S.” True Leaf Pet signed on after discussions with CLA earlier this year and is now in the on-boarding process with the firm as it moves into the busy spring season.
CLA Executive Bob Haege says True Leaf Pet was a great fit “because they have an innovative product line that meets U.S. regulatory criteria, led by a great team with vast industry experience.”
“We see True Hemp™ as a growth engine for stores looking for a legal and effective product line for hemp-friendly consumers, especially the valuable millennial demographic.”
True Leaf Pet is now preparing for the busy trade show season and putting together the finishing touches on a newly expanded product line that will be on display at the upcoming Global Pet Expo on March 22-24 in Orlando, Florida. “We have meetings set with the CLA team and prospective customers at the show and look forward to a great response to our new products,” said Mr. Bomford.


Click here to read the full press release.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less